Literature DB >> 7924779

The incidence of childhood IDDM in New South Wales, Australia.

C F Verge1, M Silink, N J Howard.   

Abstract

OBJECTIVE: To determine the incidence of insulin-dependent diabetes mellitus (IDDM) in children 0-14 years of age in the state of New South Wales, Australia, which has a total population of 5.73 million. RESEARCH DESIGN AND METHODS: We established a prospective register, identifying 361 incident cases over a 2-year period (1990-1991) with two independent sources of case ascertainment. The primary source was the reporting of newly diagnosed patients by physicians and diabetes educators. The secondary source was a subsidized syringe scheme.
RESULTS: Using the capture-recapture method, ascertainment was estimated to be 99.4% complete. The age-standardized incidence rate was 14.5 per 100,000 person-years (95% confidence interval: 13.0-16.0). No significant differences were found when comparing the first and second years of the register, boys and girls, geographical areas, or Aboriginal and non-Aboriginal children. There was seasonal variation in the onset (with more cases in winter), which was evident in the 10- to 14-year age-group (P = 0.01), but not in younger age-groups. A first-degree relative was already affected in 6.9% of the cases. No significant difference was noted in the age at onset when comparing cases with and without an affected first-degree relative.
CONCLUSIONS: The incidence of childhood IDDM in New South Wales is similar to rates found in other predominantly Anglo-Saxon populations. IDDM occurs in Aboriginal children with a frequency comparable to that in the rest of the population.

Entities:  

Mesh:

Year:  1994        PMID: 7924779     DOI: 10.2337/diacare.17.7.693

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  7 in total

1.  Younger age at diagnosis of type 1 diabetes mellitus in children of immigrated families born in Italy.

Authors:  F Cadario; A Vercellotti; M Trada; M Zaffaroni; A Rapa; D Iafusco; S Salardi; R Baldelli; G Bona
Journal:  J Endocrinol Invest       Date:  2004-11       Impact factor: 4.256

2.  Seasonality in clinical onset of type 1 diabetes in belgian patients above the age of 10 is restricted to HLA-DQ2/DQ8-negative males, which explains the male to female excess in incidence.

Authors:  I Weets; L Kaufman; B Van der Auwera; L Crenier; R P A Rooman; C De Block; K Casteels; E Weber; M Coeckelberghs; Z Laron; D G Pipeleers; F K Gorus
Journal:  Diabetologia       Date:  2004-04       Impact factor: 10.122

3.  Continued increase in the incidence of childhood Type 1 diabetes in a population-based Australian sample (1985-2002).

Authors:  A Haynes; C Bower; M K Bulsara; T W Jones; E A Davis
Journal:  Diabetologia       Date:  2004-04-17       Impact factor: 10.122

4.  Anti-glutamate decarboxylase and other antibodies at the onset of childhood IDDM: a population-based study.

Authors:  C F Verge; N J Howard; M J Rowley; I R Mackay; P Z Zimmet; M Egan; H Hulinska; I Hulinsky; R A Silvestrini; S Kamath
Journal:  Diabetologia       Date:  1994-11       Impact factor: 10.122

Review 5.  Global and regional estimates of the morbidity due to type I diabetes among children aged 0-4 years: a systematic review and analysis.

Authors:  Davies Adeloye; Kit Yee Chan; Natasha Thorley; Charlotte Jones; David Johnstone; Ari L'Heveder; Vanja Saftic; David Henderson; Mickey Chopra; Harry Campbell; Igor Rudan
Journal:  J Glob Health       Date:  2018-12       Impact factor: 4.413

6.  Hidden diabetes in the UK: use of capture-recapture methods to estimate total prevalence of diabetes mellitus in an urban population.

Authors:  Geoffrey V Gill; Aziz A Ismail; Nicholas J Beeching; Sarah B J Macfarlane; Mark A Bellis
Journal:  J R Soc Med       Date:  2003-07       Impact factor: 18.000

Review 7.  Prevalence and incidence of type 1 diabetes in the world: a systematic review and meta-analysis.

Authors:  Majid Mobasseri; Masoud Shirmohammadi; Tarlan Amiri; Nafiseh Vahed; Hossein Hosseini Fard; Morteza Ghojazadeh
Journal:  Health Promot Perspect       Date:  2020-03-30
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.